Related references
Note: Only part of the references are listed.Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples
Caroline E. Ghiossi et al.
JOURNAL OF GENETIC COUNSELING (2018)
Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification
Gregory J. Hogan et al.
CLINICAL CHEMISTRY (2018)
Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results
Stephanie A. Kraft et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network
Rebecca C. Spillmann et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Cystic fibrosis carrier screening effects on birth prevalence and newborn screening
Carlo Castellani et al.
GENETICS IN MEDICINE (2016)
Expanded carrier screening in an infertile population: how often is clinical decision making affected?
Jason M. Franasiak et al.
GENETICS IN MEDICINE (2016)
Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening
Imran S. Haque et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics
Michael Watson
GENETICS IN MEDICINE (2015)
Expanded Carrier Screening in Reproductive Medicine-Points to Consider A Joint Statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine
Janice G. Edwards et al.
OBSTETRICS AND GYNECOLOGY (2015)
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing
Pe'er Dar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels
Gabriel A. Lazarin et al.
PLOS ONE (2014)
An empirical estimate of carrier frequencies for 400+causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals
Gabriel A. Lazarin et al.
GENETICS IN MEDICINE (2013)
Uptake of invasive prenatal tests in pregnancies conceived via assisted reproductive technologies: the experience in Queensland, Australia
Lauren Hunt et al.
PRENATAL DIAGNOSIS (2012)
Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services
Robert Currier et al.
PRENATAL DIAGNOSIS (2012)
Medicare and Medical Technology - The Growing Demand for Relevant Outcomes
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Association Between Carrier Screening and Incidence of Cystic Fibrosis
Carlo Castellani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Carrier screening for spinal muscular atrophy
Thomas W. Prior
GENETICS IN MEDICINE (2008)
Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study
A. C. Gjerris et al.
HUMAN REPRODUCTION (2008)
Newborn screening showing decreasing incidence of cystic fibrosis
Jaime E. Hale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Results from the north Cyprus Thalassemia Prevention Program
Gulsen Bozkurt
HEMOGLOBIN (2007)
Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model
MM Kaback
EUROPEAN JOURNAL OF PEDIATRICS (2000)
Share Paper
